An Exeter Hospital hand surgeon's work is connecting carpal tunnel syndrome to a rare, life-threatening heart condition— and ...
Zacks Investment Research on MSN2d
Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
(1-3) About Hereditary ATTR (hATTR) Amyloidosis hATTR amyloidosis is an inherited, rapidly progressive, debilitating, and fatal disease characterized by the accumulation of a misfolded protein.
In 2007, after 15 years of seeing numerous doctors and specialists, 15 years of misdiagnoses and 15 years of being viewed as a hypochondriac, on my birthday I was diagnosed with primary systemic AL am ...
The leading AL Amyloidosis Companies such as Caelum Biosciences, Nexcella, Inc., HaemaLogiX Ltd., Prothena, ZENTALIS PHARMACEUTICALS, Sorrento Therapeutics, Inc., and others.
In this deep dive, BioSpace explores the diverse therapeutic modalities now in development, as well as the opportunities and ...
Erythropoietin-producing hepatoma (Eph) receptors, including EphA4, are expressed on the cell surface and involved in brain development, which involves extensive pruning of synapses. A variant in ...
They found that in the CA1 region, EphA4 expression increased in both pyramidal neurons and in astrocytes as amyloidosis worsened and the number of synapses fell. This was prevented by treating these ...
Ionis Pharmaceuticals (IONS) announced that Ionis and AstraZeneca’s (AZN) WAINZUA eplontersen has been approved in the European Union EU for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback